Efficacy of customized corneal crosslinking versus standard corneal crosslinking in patients with progressive keratoconus (C-CROSS study): study protocol for a randomized controlled trial

BACKGROUND: Keratoconus is a degenerative disorder of the cornea leading to a protrusion and thinning with loss of visual acuity. The only treatment to halt the progression is corneal crosslinking (CXL), which uses riboflavin and UV-A light to stiffen the cornea. Recent ultra-structural examinations...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandevenne, Magali M. S., Berendschot, Tos T. J. M., Winkens, Bjorn, van den Biggelaar, Frank J. H. M., Visser, Nienke, Dickman, Mor M., Wisse, Robert P. L., Wijdh, Robert-Jan H. J., Roy, Abhijit Sinha, Shetty, Rohit, Nuijts, Rudy M. M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197381/
https://www.ncbi.nlm.nih.gov/pubmed/37208674
http://dx.doi.org/10.1186/s12886-023-02976-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197381/
https://www.ncbi.nlm.nih.gov/pubmed/37208674
http://dx.doi.org/10.1186/s12886-023-02976-4

Ejemplares similares